Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Мерсана Терапьютикс, Инк.filedCriticalМерсана Терапьютикс, Инк.
Priority claimed from PCT/US2019/046852external-prioritypatent/WO2020037225A1/en
Publication of EA202190541A1publicationCriticalpatent/EA202190541A1/en
В изобретении описаны режимы дозирования для нацеленных на NaPi2b конъюгатов антитело-лекарственное средство для лечения злокачественной опухоли.The invention describes dosage regimens for NaPi2b targeting antibody-drug conjugates for the treatment of cancer.
EA202190541A2019-05-302019-08-16
POLYMER-ANTIBODY CONJUGATES TARGETED ON NaPi2b, DRUG AND METHODS OF THEIR APPLICATION
EA202190541A1
(en)